{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T16:05:22Z","timestamp":1783181122529,"version":"3.54.6"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T00:00:00Z","timestamp":1773187200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004332","name":"Seoul National University Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004332","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["RS-2023\\u201300241411"],"award-info":[{"award-number":["RS-2023\\u201300241411"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["0420250270"],"award-info":[{"award-number":["0420250270"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.biopha.2026.119217","type":"journal-article","created":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T09:31:20Z","timestamp":1773653480000},"page":"119217","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Human iPSC-derived exosomes for amelioration of Huntington\u2019s disease through mitochondrial, synaptic, and anti-apoptotic mechanisms"],"prefix":"10.1016","volume":"197","author":[{"given":"Seoho","family":"Jahng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-1886-3780","authenticated-orcid":false,"given":"Nuria","family":"Palomar-Alonso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1282-4528","authenticated-orcid":false,"given":"Jangsup","family":"Moon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Byung Guk","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mijung","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manho","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.biopha.2026.119217_bib1","article-title":"Huntington disease","volume":"1","author":"Bates","year":"2015","journal-title":"Nat. Rev. Dis. Prim."},{"issue":"3","key":"10.1016\/j.biopha.2026.119217_bib2","doi-asserted-by":"crossref","DOI":"10.1038\/emm.2014.117","article-title":"Degradation of misfolded proteins in neurodegenerative diseases: therapeutic targets and strategies","volume":"47","author":"Ciechanover","year":"2015","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.biopha.2026.119217_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2025.117827","article-title":"The role of mitochondrial dysfunction in Huntington's disease: implications for therapeutic targeting","volume":"183","author":"Joshi","year":"2025","journal-title":"Biomed. Pharm."},{"issue":"6","key":"10.1016\/j.biopha.2026.119217_bib4","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-E","article-title":"A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes","volume":"72","author":"MacDonald","year":"1993","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.biopha.2026.119217_bib5","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1002\/mdc3.14029","article-title":"Systemic symptoms in Huntington's disease: a comprehensive review","volume":"11","author":"Mehanna","year":"2024","journal-title":"Mov. Disord. Clin. Pr."},{"key":"10.1016\/j.biopha.2026.119217_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2024.176873","article-title":"Emerging pharmacological approaches for Huntington's disease","volume":"980","author":"Singh","year":"2024","journal-title":"Eur. J. Pharm."},{"issue":"5","key":"10.1016\/j.biopha.2026.119217_bib7","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1002\/mdc3.14029","article-title":"Systemic symptoms in Huntington's disease: a comprehensive review","volume":"11","author":"Mehanna","year":"2024","journal-title":"Mov. Disord. Clin. Pract."},{"key":"10.1016\/j.biopha.2026.119217_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2025.117827","article-title":"The role of mitochondrial dysfunction in Huntington\u2019s disease: Implications for therapeutic targeting","volume":"183","author":"Joshi","year":"2025","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.biopha.2026.119217_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2024.176873","article-title":"Emerging pharmacological approaches for Huntington's disease","volume":"980","author":"Singh","year":"2024","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.biopha.2026.119217_bib10","article-title":"The evolving landscape of stem cell therapies for Huntington's disease","author":"Estarellas","year":"2025","journal-title":"Mol. Diagn. Ther."},{"key":"10.1016\/j.biopha.2026.119217_bib11","article-title":"The evolving landscape of stem cell therapies for Huntington\u2019s disease","author":"Estarellas","year":"2025","journal-title":"Mol. Diagn. Ther."},{"issue":"9","key":"10.1016\/j.biopha.2026.119217_bib12","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.4103\/1673-5374.390969","article-title":"Therapeutic advances in neural regeneration for Huntington's disease","volume":"19","author":"D'Egidio","year":"2024","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.biopha.2026.119217_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.brainresbull.2023.110673","article-title":"Advances in stem cell and other therapies for Huntington's disease: an update","volume":"199","author":"Conner","year":"2023","journal-title":"Brain Res. Bull."},{"issue":"5","key":"10.1016\/j.biopha.2026.119217_bib14","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1093\/procel\/pwae042","article-title":"Advances in gene and cellular therapeutic approaches for Huntington's disease","volume":"16","author":"Piao","year":"2025","journal-title":"Protein Cell"},{"key":"10.1016\/j.biopha.2026.119217_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.brainresbull.2023.110673","article-title":"Advances in stem cell and other therapies for Huntington\u2019s disease: an update","volume":"199","author":"Conner","year":"2023","journal-title":"Brain Res. Bull."},{"issue":"5","key":"10.1016\/j.biopha.2026.119217_bib16","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1093\/procel\/pwae042","article-title":"Advances in gene and cellular therapeutic approaches for Huntington\u2019s disease","volume":"16","author":"Piao","year":"2024","journal-title":"Protein Cell"},{"issue":"11","key":"10.1016\/j.biopha.2026.119217_bib17","doi-asserted-by":"crossref","first-page":"17802","DOI":"10.1021\/acsnano.2c08774","article-title":"Exosomes\u2500nature's lipid nanoparticles, a rising star in drug delivery and diagnostics","volume":"16","author":"Tenchov","year":"2022","journal-title":"ACS Nano"},{"issue":"6478","key":"10.1016\/j.biopha.2026.119217_bib18","doi-asserted-by":"crossref","DOI":"10.1126\/science.aau6977","article-title":"The biology, function, and biomedical applications of exosomes","volume":"367","author":"Kalluri","year":"2020","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.biopha.2026.119217_bib19","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1111\/ejn.13275","article-title":"Exosomes from adipose-derived stem cells ameliorate phenotype of Huntington's disease in vitro model","volume":"44","author":"Lee","year":"2016","journal-title":"Eur. J. Neurosci."},{"issue":"7","key":"10.1016\/j.biopha.2026.119217_bib20","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1038\/s41419-022-05034-x","article-title":"Mesenchymal stem cell-derived extracellular vesicles for immunomodulation and regeneration: a next generation therapeutic tool?","volume":"13","author":"Kou","year":"2022","journal-title":"Cell Death Dis."},{"issue":"5","key":"10.1016\/j.biopha.2026.119217_bib21","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1038\/mt.2015.44","article-title":"Mesenchymal stem cell-derived extracellular vesicles: toward cell-free therapeutic applications","volume":"23","author":"Rani","year":"2015","journal-title":"Mol. Ther."},{"issue":"1","key":"10.1016\/j.biopha.2026.119217_bib22","article-title":"Extracellular vesicles from human iPSC-derived neural stem cells: miRNA and protein signatures, and anti-inflammatory and neurogenic properties","volume":"9","author":"Upadhya","year":"2020","journal-title":"J. Extra Vesicles"},{"issue":"19","key":"10.1016\/j.biopha.2026.119217_bib23","doi-asserted-by":"crossref","first-page":"19546","DOI":"10.18632\/aging.103904","article-title":"Comparison of exosomes derived from induced pluripotent stem cells and mesenchymal stem cells as therapeutic nanoparticles for treatment of corneal epithelial defects","volume":"12","author":"Wang","year":"2020","journal-title":"Aging (Albany NY)"},{"issue":"2","key":"10.1016\/j.biopha.2026.119217_bib24","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1093\/cvr\/cvad185","article-title":"Induced pluripotent stem cell-derived exosomes attenuate vascular remodelling in pulmonary arterial hypertension by targeting HIF-1\u03b1 and Runx2","volume":"120","author":"Chi","year":"2024","journal-title":"Cardiovasc Res"},{"issue":"6","key":"10.1016\/j.biopha.2026.119217_bib25","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.stem.2008.05.005","article-title":"Human stem cell ethics: beyond the embryo","volume":"2","author":"Sugarman","year":"2008","journal-title":"Cell Stem Cell"},{"issue":"12","key":"10.1016\/j.biopha.2026.119217_bib26","doi-asserted-by":"crossref","first-page":"5371","DOI":"10.1172\/JCI70911","article-title":"Inhibition of mitochondrial fragmentation diminishes Huntington's disease-associated neurodegeneration","volume":"123","author":"Guo","year":"2013","journal-title":"J. Clin. Invest."},{"issue":"1","key":"10.1016\/j.biopha.2026.119217_bib27","doi-asserted-by":"crossref","first-page":"7027","DOI":"10.1038\/s41467-024-51216-w","article-title":"Mutant huntingtin impairs neurodevelopment in human brain organoids through CHCHD2-mediated neurometabolic failure","volume":"15","author":"Lisowski","year":"2024","journal-title":"Nat. Commun."},{"issue":"30","key":"10.1016\/j.biopha.2026.119217_bib28","doi-asserted-by":"crossref","first-page":"10034","DOI":"10.1523\/JNEUROSCI.0715-14.2014","article-title":"Mutant huntingtin affects cortical progenitor cell division and development of the mouse neocortex","volume":"34","author":"Molina-Calavita","year":"2014","journal-title":"J. Neurosci."},{"issue":"12","key":"10.1016\/j.biopha.2026.119217_bib29","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1016\/j.stem.2022.11.006","article-title":"The consequences of recurrent genetic and epigenetic variants in human pluripotent stem cells","volume":"29","author":"Andrews","year":"2022","journal-title":"Cell Stem Cell"},{"issue":"1","key":"10.1016\/j.biopha.2026.119217_bib30","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.stem.2013.12.005","article-title":"Human pluripotent stem cell culture: considerations for maintenance, expansion, and therapeutics","volume":"14","author":"Chen","year":"2014","journal-title":"Cell Stem Cell"},{"issue":"2","key":"10.1016\/j.biopha.2026.119217_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.yexcr.2022.113454","article-title":"Extracellular vesicles production and proteomic cargo varies with incubation time and temperature","volume":"422","author":"Rayamajhi","year":"2023","journal-title":"Exp. Cell Res."},{"issue":"1","key":"10.1016\/j.biopha.2026.119217_bib32","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S1474-4422(10)70245-3","article-title":"Huntington's disease: from molecular pathogenesis to clinical treatment","volume":"10","author":"Ross","year":"2011","journal-title":"Lancet Neurol."},{"issue":"1","key":"10.1016\/j.biopha.2026.119217_bib33","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s13311-013-0244-z","article-title":"Treatment of Huntington's disease","volume":"11","author":"Frank","year":"2014","journal-title":"Neurotherapeutics"},{"issue":"1","key":"10.1016\/j.biopha.2026.119217_bib34","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/ene.13413","article-title":"Huntington's disease: a clinical review","volume":"25","author":"McColgan","year":"2018","journal-title":"Eur. J. Neurol."},{"issue":"1","key":"10.1016\/j.biopha.2026.119217_bib35","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/s41593-022-01207-1","article-title":"An RNA-targeting CRISPR\u2013Cas13d system alleviates disease-related phenotypes in Huntington\u2019s disease models","volume":"26","author":"Morelli","year":"2023","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.biopha.2026.119217_bib36","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1186\/s13287-015-0248-1","article-title":"Neural and mesenchymal stem cells in animal models of Huntington's disease: past experiences and future challenges","volume":"6","author":"Kerkis","year":"2015","journal-title":"Stem Cell Res Ther."},{"issue":"1","key":"10.1016\/j.biopha.2026.119217_bib37","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/s41392-023-01704-0","article-title":"Clinical applications of stem cell-derived exosomes","volume":"9","author":"Tan","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"issue":"1","key":"10.1016\/j.biopha.2026.119217_bib38","doi-asserted-by":"crossref","DOI":"10.3402\/jev.v4.30087","article-title":"Applying extracellular vesicles based therapeutics in clinical trials \u2013 an ISEV position paper","volume":"4","author":"Lener","year":"2015","journal-title":"J. Extracell. Vesicles"},{"issue":"11","key":"10.1016\/j.biopha.2026.119217_bib39","doi-asserted-by":"crossref","DOI":"10.1002\/jev2.12519","article-title":"Extracellular vesicles from human-induced pluripotent stem cell-derived neural stem cells alleviate proinflammatory cascades within disease-associated microglia in Alzheimer's disease","volume":"13","author":"Madhu","year":"2024","journal-title":"J. Extracell. Vesicles"},{"key":"10.1016\/j.biopha.2026.119217_bib40","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2023.1200445","article-title":"Intranasally administered extracellular vesicles from human induced pluripotent stem cell-derived neural stem cells quickly incorporate into neurons and microglia in 5xFAD mice","volume":"15","author":"Attaluri","year":"2023","journal-title":"Front Aging Neurosci."},{"issue":"43","key":"10.1016\/j.biopha.2026.119217_bib41","doi-asserted-by":"crossref","first-page":"37783","DOI":"10.1021\/acsnano.5c10672","article-title":"Induced pluripotent stem cell-derived extracellular vesicles prevent neural stem cell senescence to promote cognitive recovery after traumatic brain injury","volume":"19","author":"Chen","year":"2025","journal-title":"ACS Nano"},{"issue":"1","key":"10.1016\/j.biopha.2026.119217_bib42","doi-asserted-by":"crossref","first-page":"45","DOI":"10.14802\/jmd.16054","article-title":"Exosome-based delivery of miR-124 in a Huntington's disease model","volume":"10","author":"Lee","year":"2017","journal-title":"J. Mov. Disord."},{"issue":"11","key":"10.1016\/j.biopha.2026.119217_bib43","doi-asserted-by":"crossref","first-page":"2896","DOI":"10.1016\/j.cell.2021.04.027","article-title":"Mitocytosis, a migrasome-mediated mitochondrial quality-control process","volume":"184","author":"Jiao","year":"2021","journal-title":"Cell"},{"issue":"7","key":"10.1016\/j.biopha.2026.119217_bib44","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1002\/stem.1129","article-title":"Exosome-mediated transfer of miR-133b from multipotent mesenchymal stromal cells to neural cells contributes to neurite outgrowth","volume":"30","author":"Xin","year":"2012","journal-title":"Stem Cells"},{"issue":"9","key":"10.1016\/j.biopha.2026.119217_bib45","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1038\/nrc883","article-title":"The Bcl2 family: regulators of the cellular life-or-death switch","volume":"2","author":"Cory","year":"2002","journal-title":"Nat. Rev. Cancer"},{"issue":"1","key":"10.1016\/j.biopha.2026.119217_bib46","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1007\/s10571-024-01460-x","article-title":"A new strategy for the regulation of neuroinflammation: exosomes derived from mesenchymal stem cells","volume":"44","author":"Ge","year":"2024","journal-title":"Cell Mol. Neurobiol."},{"key":"10.1016\/j.biopha.2026.119217_bib47","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2021.105445","article-title":"Extracellular vesicles in the treatment of neurological disorders","volume":"157","author":"Reed","year":"2021","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.biopha.2026.119217_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2021.105374","article-title":"Exosomes as a potential messenger unit during heterochronic parabiosis for amelioration of Huntington's disease","volume":"155","author":"Lee","year":"2021","journal-title":"Neurobiol. Dis."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332226002507?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332226002507?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T12:28:51Z","timestamp":1776083331000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332226002507"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":48,"alternative-id":["S0753332226002507"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2026.119217","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Human iPSC-derived exosomes for amelioration of Huntington\u2019s disease through mitochondrial, synaptic, and anti-apoptotic mechanisms","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2026.119217","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"119217"}}